The innovative achievements of Shanghai's top tertiary hospitals are accelerating the industrialization process. News came from the Second Shanghai Clinical Transformation Ecological Forum of "Clinical Transformation·Financial Empowerment" held on March 21: The "hospital patent licensing + temporary transfer hospital cash investment" intellectual property corporatization operating model has promoted a number of hospital innovation results to embark on the corporatization process.
The forum is guided by Shanghai Shenkang Hospital Development Center and Shanghai State-owned Capital Investment Co., Ltd., and co-sponsored by Shanghai Clinical Innovation and Transformation Research Institute, Shanghai Futeng Private Equity Fund Management Co., Ltd., and Bank of Shanghai Co., Ltd. At the forum, Duan Qi, President of the Transient Hospital, Zheng Xingdong, President of Shanghai First People's Hospital, Ma Yanbin, Secretary of the Party Committee of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and Sun Fenyong, Vice President of Shanghai Tenth People's Hospital, jointly signed the second batch of intellectual property corporatization operation projects.
As the first transformation model for temporary transfer hospitals, the "hospital patent licensing + temporary hospital cash investment" intellectual property corporatization operating model has promoted 8 projects to complete company registration or is starting the company registration process since the first project was launched in 2025, successfully attracting the participation of industries and investors from all over the country, with a total planned investment of approximately 90 million yuan.
The signing of the second batch of projects marks the transition of this model from a "single-point pilot" to a stage of large-scale application that can be "replicated and promoted". Wang Xingpeng, chairman of the hospital, said that the hospital will continue to deepen mechanism innovation and help open up the "last mile" of medical innovation.
The forum also officially launched the 2026 second "SDIC Futeng Cup" Yangtze River Delta Clinical Innovation and Entrepreneurship Competition. The scope of the competition has been expanded from Shanghai to the Yangtze River Delta, accelerating the construction of a "discovery-cultivation-transformation-investment" full-chain support system, linking the Bank of Shanghai donation fund and the transfer hospital seed fund to provide all-round support for participating projects and promote the coordinated development of the regional clinical transformation ecosystem.
As a key brand activity of the hospital in 2025, the first "SDIC Futeng Cup" Clinical Innovation and Entrepreneurship Competition came to an end, and an award ceremony was held at the forum. The award-winning projects include 51 high-quality projects with transformation potential from more than 20 Shanghai municipal hospitals, including Shanghai First People's Hospital, Shanghai Sixth People's Hospital, Shanghai Tenth People's Hospital, Shanghai Ninth People's Hospital and Shanghai Pulmonary Hospital, as well as district-level hospitals, covering medical devices, digital medicine, biomedicine, AI-assisted diagnosis and treatment and other fields.
The Bank of Shanghai's special public welfare fund was officially launched on site, focusing on the early R&D and pilot trials of high-quality projects in the temporary transfer hospital, injecting financial "living water" into clinical transformation.
The transfer hospital stated that it will continue to explore the "Shanghai Path" for clinical transformation, promote more innovative results from the laboratory to the bedside with a more complete mechanism, stronger financial support, and better ecological services, and inject strong impetus into Shanghai's construction of a global biomedical innovation hub.
